Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations
about
The Role of gsp Mutations on the Development of Adrenocortical Tumors and Adrenal HyperplasiaWhole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.Cushing's syndrome in childhood: update on genetics, treatment, and outcomes.Phosphodiesterase sequence variants may predispose to prostate cancer.A pathological perspective on the natural history of cerebral atherosclerosisCholesterol Biosynthesis and Trafficking in Cortisol-Producing Lesions of the Adrenal Cortex.Regulation of the adrenocortical stem cell niche: implications for diseasecAMP/PKA signaling defects in tumors: genetics and tissue-specific pluripotential cell-derived lesions in human and mouse.PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour developmentPhosphodiesterase 8B and cyclic AMP signaling in the adrenal cortex.Celecoxib treatment of fibrous dysplasia (FD) in a human FD cell line and FD-like lesions in mice with protein kinase A (PKA) defects.A genetic and molecular update on adrenocortical causes of Cushing syndrome.Cell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia.Genetics of Adrenocortical Development and Tumors.Persistent Diabetes Mellitus Postadrenalectomy in Neonatal McCune-Albright Syndrome.[New aspects of tumor pathology of the adrenal glands].Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
P2860
Q26741915-13507C91-96A3-45D5-8A35-BE2050589D1BQ33570215-2CC5B72D-8871-4DCB-AA80-CA265534DEB7Q33682397-4D65183C-D3B6-4A4E-AA63-6360812CE1B5Q35555316-5DA0A880-990A-493C-9E8B-C18DA73386ACQ35843428-4B4002FE-9BCE-4296-B251-941DBFDFD231Q36095012-0DBA349F-1C55-423A-B6F7-1853F86C18F3Q36129799-8962C997-F921-4FF2-9AC9-880B32557459Q36288064-D9705B11-723C-4712-850D-6B3086F91FA7Q36763148-BE4E2596-B082-49EF-8E68-8834B1DA9326Q37263731-3EFF2B40-403C-485C-9A2E-5D952C548520Q38478325-E60458A0-07CC-43B7-9D3F-D2E41AEF25F1Q38753349-8873CBA4-97EF-46C3-B129-54915E460654Q38769185-C4DC614D-F532-47D8-BC89-7822FB3BA744Q39035325-A701125A-74B1-4418-AF33-D1EB0A866518Q39286333-C6044AD9-1563-4E00-A7DE-1F78A899A786Q47117204-3BF60292-5CB5-42B6-A728-9759A34A7325Q53519234-30189996-D02F-4D6B-97AE-D999376BB7D4Q54240213-722B59A8-5C37-4FE0-8C35-5097F582F072
P2860
Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Activation of cyclic AMP signa ...... due to somatic GNAS mutations
@ast
Activation of cyclic AMP signa ...... due to somatic GNAS mutations
@en
type
label
Activation of cyclic AMP signa ...... due to somatic GNAS mutations
@ast
Activation of cyclic AMP signa ...... due to somatic GNAS mutations
@en
prefLabel
Activation of cyclic AMP signa ...... due to somatic GNAS mutations
@ast
Activation of cyclic AMP signa ...... due to somatic GNAS mutations
@en
P2093
P2860
P356
P1476
Activation of cyclic AMP signa ...... due to somatic GNAS mutations
@en
P2093
Anelia Horvath
Chris Cheadle
Eirini I Bimpaki
George S Jeha
Isabelle Bourdeau
Lefkothea P Karaviti
Madson Q Almeida
Maria Nesterova
Michael T Collins
Monalisa F Azevedo
P2860
P304
P356
10.1210/JC.2011-3000
P407
P577
2012-01-18T00:00:00Z